Evaluation of Serum Levels and Expression of Galectin-4 in Cervical Cancer

Autor: Maricruz Anaya-Ruiz, Gustavo Lopez-Lopez, Aurelio López-Colombo, Francisco Javier Ceja-Utrera, Guadalupe Delgado-Lopez, Julio Reyes-Leyva, Juan Carlos Flores-Alonso, Erick Armenta-Castro, Salvador Reyes-Salinas, Verónica Vallejo-Ruiz, Victor Javier Vazquez-Zamora, Claudia T. Gutiérrez-Quiroz, Ivonne Ramírez-Díaz, Ileana Conde-Rodríguez
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: BioMed Research International, Vol 2020 (2020)
ISSN: 2314-6133
DOI: 10.1155/2020/6756723
Popis: Galectin-4 has been reported to be altered in different cancer types. Its expression changes have been associated with early recurrence and metastasis. In cervical cancer (CC), galectin-4 has not been studied. The aim of the study was to determine the expression level and subcellular localization of galectin-4 in CC tissue and the concentration in the serum of patients with CC. For the analysis of serum levels of galectin-4, an ELISA assay was performed. To assess the expression in cervical tissue, immunohistochemical staining was performed. The results showed that the concentration of galectin-4 in the serum of patients with CC was higher (647.9 pg/ml) than that in the serum of women with normal cytology (382.1 pg/ml). The immunohistochemical analysis of CC samples showed a higher expression in keratinizing tumor than nonkeratinizing tumors and a trend of increased expression in tumors from patients with advanced clinical stage. In normal cervical tissue, galectin-4 was detected in the cytoplasm, and in tumor cells, the presence of galectin-4 was also detected in the nucleus, in both adenocarcinoma and squamous cervical cancer. The increase in serum concentration and different localization in the tumor cells suggest a possible role of galectin-4 in CC development.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje